Human DN T cells inhibit autologous CD4+ and CD8+ T cell proliferation in vitro[9], [10], and the frequency of circulating DN T cells inversely correlated with the severity of GVHD in bone marrow transplantation (BMT) patients, suggesting that DN T cells might inhibit GVHD in humans [11]. Here, CD8A is linked to graft versus host disease.